Literature DB >> 3099298

Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene.

C W Benjamin, W G Tarpley, R R Gorman.   

Abstract

Data indicating that the 21-kDa protein (p21) Harvey-ras gene product shares sequence homology with guanine nucleotide-binding proteins (G proteins) has stimulated research on the influence(s) of p21 on G-protein-regulated systems in vertebrate cells. Our previous work demonstrated that NIH-3T3 mouse cells expressing high levels of the cellular ras oncogene isolated from the EJ human bladder carcinoma (EJ-ras) exhibited reduced hormone-stimulated adenylate cyclase activity. We now report that in these cells another enzyme system thought to be regulated by G proteins is inhibited, namely phospholipases A2 and C. NIH-3T3 cells incubated in plasma-derived serum release significant levels of prostaglandin E2 (PGE2) as determined by radioimmunoassay when exposed to platelet-derived growth factor (PDGF) at 2 units/ml; the levels of PGE2 released from EJ-ras-transfected cells are only 3% those of controls despite a similar basal (unstimulated) release from control and EJ-ras-transfected cells. The lack of PDGF-stimulated PGE2 release from EJ-ras-transfected cells is not due to a defect in the prostaglandin cyclooxygenase enzyme, since incubation of control cells and EJ-ras-transfected cells in 0.33, 3.3, or 33 microM arachidonate resulted in identical levels of PGE2 release. The lack of PDGF-stimulated PGE2 release from EJ-ras-transfected cells also does not result from the loss of functional PDGF receptors. EJ-ras-transformed cells bind 70% as much 125I-labeled PDGF as control cells and are stimulated to incorporate [3H]thymidine and to proliferate after exposure to PDGF. Moreover, this inhibition is not likely the result of a secondary cellular effect related to the transformed phenotype, since NIH-3T3 cells transformed by v-src released PGE2 at wild-type levels after exposure to PDGF. Determination of total water-soluble inositolphospholipids and changes in the specific activities of phosphatidylcholine in control and EJ-ras-transfected cells demonstrated that PDGF-stimulated phospholipase C and A2 activities are inhibited in the EJ-ras-transfected cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3099298      PMCID: PMC304246          DOI: 10.1073/pnas.84.2.546

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  The 1985 Catalog of Mapped Genes and report of the Nomenclature Committee.

Authors:  P J McAlpine; T B Shows; R L Miller; A J Pakstis
Journal:  Cytogenet Cell Genet       Date:  1985

2.  Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1.

Authors:  A Hall; C J Marshall; N K Spurr; R A Weiss
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

3.  Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor.

Authors:  A J Habenicht; J A Glomset; R Ross
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

4.  Purification of human platelet-derived growth factor.

Authors:  H N Antoniades; C D Scher; C D Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

5.  Prostaglandins in human seminal plasma. Prostaglandins and related factors 46.

Authors:  M Hamberg; B Samuelsson
Journal:  J Biol Chem       Date:  1966-01-25       Impact factor: 5.157

6.  Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia.

Authors:  J L Bos; D Toksoz; C J Marshall; M Verlaan-de Vries; G H Veeneman; A J van der Eb; J H van Boom; J W Janssen; A C Steenvoorden
Journal:  Nature       Date:  1985 Jun 27-Jul 3       Impact factor: 49.962

7.  ras-transformed cells: altered levels of phosphatidylinositol-4,5-bisphosphate and catabolites.

Authors:  L F Fleischman; S B Chahwala; L Cantley
Journal:  Science       Date:  1986-01-24       Impact factor: 47.728

8.  Comparative biochemical properties of normal and activated human ras p21 protein.

Authors:  J P McGrath; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

9.  The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity.

Authors:  R W Sweet; S Yokoyama; T Kamata; J R Feramisco; M Rosenberg; M Gross
Journal:  Nature       Date:  1984 Sep 20-26       Impact factor: 49.962

10.  Early changes in inositol lipids and their metabolites induced by platelet-derived growth factor in quiescent Swiss mouse 3T3 cells.

Authors:  H Hasegawa-Sasaki
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

View more
  22 in total

1.  Specific changes of Ras GTPase-activating protein (GAP) and a GAP-associated p62 protein during calcium-induced keratinocyte differentiation.

Authors:  E Filvaroff; E Calautti; F McCormick; G P Dotto
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene.

Authors:  B J Ledwith; S Manam; A R Kraynak; W W Nichols; M O Bradley
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

Review 3.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

4.  Oncogene N-ras mediates selective inhibition of c-fos induction by nerve growth factor and basic fibroblast growth factor in a PC12 cell line.

Authors:  T M Thomson; S H Green; R J Trotta; D E Burstein; A Pellicer
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

5.  Alterations of G-protein coupling function in phosphoinositide signaling pathways of cells transformed by ras and other membrane-associated and cytoplasmic oncogenes.

Authors:  T Alonso; S Srivastava; E Santos
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

6.  Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene.

Authors:  M Satake; T Ibaraki; Y Yamaguchi; Y Ito
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells.

Authors:  T Satoh; M Endo; M Nakafuku; S Nakamura; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

8.  Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogene.

Authors:  A H Lin; V E Groppi; R R Gorman
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

9.  NIH-3T3 cells transformed by the EJ-ras oncogene exhibit reduced platelet-derived growth factor-mediated Ca2+ mobilization.

Authors:  C W Benjamin; J A Connor; W G Tarpley; R R Gorman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Possible involvement of normal p21 H-ras in the insulin/insulinlike growth factor 1 signal transduction pathway.

Authors:  B M Burgering; A J Snijders; J A Maassen; A J van der Eb; J L Bos
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.